Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1986 1
1987 17
1988 16
1989 42
1990 23
1991 66
1992 98
1993 149
1994 166
1995 217
1996 322
1997 375
1998 433
1999 416
2000 441
2001 477
2002 472
2003 447
2004 411
2005 435
2006 360
2007 377
2008 353
2009 363
2010 372
2011 387
2012 426
2013 465
2014 484
2015 506
2016 487
2017 484
2018 496
2019 541
2020 588
2021 581
2022 536
2023 496
2024 162

Text availability

Article attribute

Article type

Publication date

Search Results

12,526 results

Results by year

Filters applied: . Clear all
Page 1
Clarithromycin clinical pharmacokinetics.
Fraschini F, Scaglione F, Demartini G. Fraschini F, et al. Clin Pharmacokinet. 1993 Sep;25(3):189-204. doi: 10.2165/00003088-199325030-00003. Clin Pharmacokinet. 1993. PMID: 8222460 Review.
Clarithromycin is a semisynthetic macrolide antibiotic, structurally related to erythromycin. ...Clarithromycin is well distributed throughout the body and achieves higher concentrations in tissues than in the blood. ...
Clarithromycin is a semisynthetic macrolide antibiotic, structurally related to erythromycin. ...Clarithromycin is well distri …
Clarithromycin-induced hepatotoxicity.
Brown BA, Wallace RJ Jr, Griffith DE, Girard W. Brown BA, et al. Clin Infect Dis. 1995 Apr;20(4):1073-4. doi: 10.1093/clinids/20.4.1073. Clin Infect Dis. 1995. PMID: 7795060 Review. No abstract available.
Clarithromycin as an adjunct to periodontal therapy: a systematic review and meta-analysis.
Bashir NZ, Sharma P. Bashir NZ, et al. Int J Dent Hyg. 2022 Feb;20(1):75-86. doi: 10.1111/idh.12498. Epub 2021 May 5. Int J Dent Hyg. 2022. PMID: 33773046 Review.
OBJECTIVE: To collate the literature evaluating the efficacy of clarithromycin as an adjunct to non-surgical periodontal therapy and conduct meta-analyses for changes in probing pocket depth (PPD) and clinical attachment level (CAL). ...No adverse events were observed. CON …
OBJECTIVE: To collate the literature evaluating the efficacy of clarithromycin as an adjunct to non-surgical periodontal therapy and …
Clarithromycin.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):92-5. doi: 10.1016/S1472-9792(08)70005-2. Tuberculosis (Edinb). 2008. PMID: 18486039 Review. No abstract available.
Azithromycin and clarithromycin.
Schlossberg D. Schlossberg D. Med Clin North Am. 1995 Jul;79(4):803-15. doi: 10.1016/s0025-7125(16)30040-2. Med Clin North Am. 1995. PMID: 7791424 Review.
Azithromycin and clarithromycin are alternatives to conventional macrolides in the routine treatment of many dermatologic, upper respiratory, and lower respiratory tract infections. ...In addition to their role as alternatives to conventional macrolide therapy, azithromyci …
Azithromycin and clarithromycin are alternatives to conventional macrolides in the routine treatment of many dermatologic, upper resp …
Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
Darkes MJ, Perry CM. Darkes MJ, et al. Am J Respir Med. 2003;2(2):175-201. doi: 10.1007/BF03256648. Am J Respir Med. 2003. PMID: 14720016 Review.
In patients with acute maxillary sinusitis, a 14-day course of either once-daily clarithromycin extended-release or twice-daily clarithromycin immediate-release produced statistically equivalent clinical cure rates of 85% and 79%, respectively. ...The reformulation …
In patients with acute maxillary sinusitis, a 14-day course of either once-daily clarithromycin extended-release or twice-daily cl …
Clarithromycin for Helicobacter pylori infection.
Leung WK, Graham DY. Leung WK, et al. Expert Opin Pharmacother. 2000 Mar;1(3):507-14. doi: 10.1517/14656566.1.3.507. Expert Opin Pharmacother. 2000. PMID: 11249534 Review.
It is an acid-stable macrolide with a broad spectrum of antibacterial activity, well absorbed with a wide tissue distribution and with mild side effects. Clarithromycin has a low minimum inhibitory concentration (MIC50) for H. pylori and its effect is potentiated by acid i …
It is an acid-stable macrolide with a broad spectrum of antibacterial activity, well absorbed with a wide tissue distribution and with mild …
Clinical pharmacokinetics of clarithromycin.
Rodvold KA. Rodvold KA. Clin Pharmacokinet. 1999 Nov;37(5):385-98. doi: 10.2165/00003088-199937050-00003. Clin Pharmacokinet. 1999. PMID: 10589373 Review.
Clarithromycin is primarily metabolised by cytochrome P450 (CYP) 3A isozymes and has an active metabolite, 14-hydroxyclarithromycin. ...In patients with severe renal impairment, increased plasma concentrations and a prolonged elimination half-life for clarithromycin …
Clarithromycin is primarily metabolised by cytochrome P450 (CYP) 3A isozymes and has an active metabolite, 14-hydroxyclarithromycin. …
12,526 results
You have reached the last available page of results. Please see the User Guide for more information.